Skip to main content

B-Trust Meditech

ApplicationSeoul, South KoreaFounded 2018· One of 462 Application companies tracked by AMPulse

A veterinary med-tech startup specializing in the development and manufacturing of metal 3D-printed orthopedic implants, notably Korea's first domestically approved artificial knee joints for animals.

CEO / Founder
Seo Jeong-woo
Team Size
1-10
Stage
Active
Total Funding
Undisclosed
Latest Round
Seed
Key Investors
Individual Angel Investors, Government-backed Tech Programs (TIPS candidate)

Technology & Products

Key Products

Rotating Hinge-type Artificial Knee Joint (Metal 3D-printed); Veterinary Artificial Hip Joint System; Artificial Patella Implants; Custom veterinary orthopedic implants

Technological Advantage

Leverages advanced metal additive manufacturing (Titanium and Cobalt-Chrome alloys) and human-level biomechanical verification to create durable, patient-optimized implants that offer significant cost advantages over imported products.

Differentiation

Value Proposition

Offers high-precision, human-grade biocompatible implants that reduce reliance on expensive imports, providing superior anatomical fit and biomechanical stability for companion animals.

How They Differentiate

B-Trust Meditech differentiates itself through 'Human-to-Pet' technology transfer, utilizing human-grade orthopedic biomechanics and metal additive manufacturing (Titanium/Cobalt-Chrome). They achieved a technical moat by being the first in South Korea to obtain product approval for 'rotating hinge-type' artificial knee joints, which offer superior anatomical stability compared to standard fixed-hinge imports.

Market & Competition

Target Customers

Veterinary specialty hospitals, orthopedic surgeons in animal clinics, and pet owners requiring advanced joint replacement surgery for dogs and cats.

Industry Verticals

Veterinary Medicine, Medical Device Manufacturing, Additive Manufacturing (Metal 3D Printing), Pet Healthcare

Competitors

Bio-Orthofix (바이오오소픽스); Pluon (플루온); BioMedtrix (Global/Import)

Growth & Milestones

Growth Metrics

Successfully moved from R&D to commercial stage in late 2024 following domestic regulatory approval; Team size 4-10 employees.

Major Milestones

Founded in 2022 focusing on veterinary medical device localization., Developed a diverse portfolio including veterinary artificial hip joints and patellar groove implants., Obtained South Korea's first domestic product approval for metal 3D-printed rotating hinge-type artificial knee joints for animals in late 2024., Established a GMP-certified quality management system specifically for 3D-printed veterinary implants.

Notable Customers

Seoul National University Veterinary Medical Teaching Hospital (Clinical Verification); Major secondary veterinary referral centers in South Korea